The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy

Status unconfirmed · Not applicable

Conditions studied: COPD, Chronic Obstructive Pulmonary Disease

In brief

The primary purpose of this study is to show whether at home usage of the AIRVO warm humidifier can potentially reduce the number of exacerbations in patients with significant respiratory insufficiency. Eligible participants of the study must have a diagnosis of chronic obstructive pulmonary disease (COPD) stage II-IV..

Key facts

Study ID

NCT03081650

Run by

Lutheran Hospital, Indiana

People needed

30

Starts

2016-08-16

Expected to finish

2017-12-01

Last updated by the study team

2017-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Have stage II-IV COPD diagnosis Understand and accept oral and written information in English Be capable of handling the AIRVO warm humidifier after instruction >18years of age

You may not qualify if…

• Comorbidity (known malignant disease, terminal illness, dementia, uncontrolled mental illness)
• Bronchiectasis without simultaneous COPD diagnosis
• Treatment with BiPAP in the home
• Affected level of consciousness
• Smoking status change during study period
• Inability to provided signed consent

Where it is running

• Lutheran hospital — Fort Wayne, Indiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.